Skip to main content

Together we are beating cancer

Donate now

Amal Iman

Amal is an accelerate intern at Cancer Research UK. She is currently working in our science policy team.
Showing 2 out of 2 results
A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025